Ann Arbor, MIDiapin Therapeutics, LLC., a company dedicated to the development of treatments for type 2 diabetes and cardiovascular disease, announced today the signing of a license agreement with the Univer

First Page		Document Content
Date: 2015-03-10 10:24:06 Chemistry Bristol-Myers Squibb Organic chemistry Business Clopidogrel Prodrugs Sanofi RTT Antiplatelet drug Thienopyridine Stroke Prasugrel		Ann Arbor, MIDiapin Therapeutics, LLC., a company dedicated to the development of treatments for type 2 diabetes and cardiovascular disease, announced today the signing of a license agreement with the Univer Add to Reading List Source URL: www.diapin.com Download Document from Source Website File Size: 66,45 KB Share Document on Facebook

	Ann Arbor, MIDiapin Therapeutics, LLC., a company dedicated to the development of treatments for type 2 diabetes and cardiovascular disease, announced today the signing of a license agreement with the Univer DocID: 1qfpV - View Document
	clopidogrel vs indocin credo clopidogrel exclusion criteria. clopidogrel acuphase high dose clopidogrel ticlopidine clopidogrel and cyclosporine a, indications for clopidogrel. clopidogrel actions. omeprazole and clopido DocID: 1pvYC - View Document
	Research Review NoA new drug to look out for. The Studies: DocID: 1oE4x - View Document
	Supplementary Material to Beyer-Westendorf et al. “Effectiveness and safety of dabigatran therapy in daily-care patients with atrial fibrillation. Results from the Dresden NOAC Registry” (Thromb Haemost 2015; 113.6) DocID: 1gsBz - View Document
	Microsoft Word - ANTIPLATELET DRUG COMPARISON CHART.doc DocID: 1cwfC - View Document